-
Combination therapy reveals potential vulnerability in aggressive osteosarcoma
10/20/2026
Explore new St. Jude research uncovering that degrading EP300 and inhibiting AKT in combination may synergize to treat sensitive metastatic osteosarcomas.
-
Charles W.M. Roberts, MD, PhD, St. Jude president and CEO-elect, named to National Academy of Medicine
10/19/2026
Learn more about St. Jude president and CEO-elect Charles W.M. Roberts, MD, PhD, who is newly named to the National Academy of Medicine.
-
National Academy of Medicine elects St. Jude physician and researcher Carsten Bönnemann, MD, habil., to its membership
10/19/2026
Learn more about St. Jude physician and researcher Carsten Bönnemann who was recently elected to the National Academy of Medicine.
-
Neighborhood conditions linked to childhood cancer survivors’ long-term health
10/14/2026
Discover how the St. Jude Lifetime Cohort Study uncovered community-level factors influencing chronic health condition risks, and how that can improve care.
-
Scientists identify the neuroblastoma cells that signal poor outcomes
10/08/2026
Explore new research that created better patient-derived models of the pediatric cancer’s high-risk variants and uncovered how to identify mesenchymal cells.
-
KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups
09/24/2026
Explore a shared vulnerability in two of the childhood brain tumor’s types, opening opportunities for targeted therapies in patients with high-risk disease.
-
Targeting ZMYND8 improves T-cell function and may boost immunotherapy
09/23/2026
Explore new St. Jude research finding how removing the immune response “brake” gene ZMYND8 led to better control of solid tumors and chronic viral infections.
-
U.S. News & World Report ranks St. Jude among top three outstanding pediatric cancer hospitals
09/15/2026
St. Jude ranked in top three outstanding pediatric hospitals in the U.S.
-
AI-informed AdaptiveFlow redefines large-scale cloud computing for drug discovery
09/01/2026
See how a machine-learning drug discovery platform for ultra-large virtual screenings called AdaptiveFlow guides the rational selection for deeper exploration
-
Findings demonstrate how mutation disrupts cell development, driving region-specific brain tumors
08/26/2026
Discover how St. Jude researchers uncovered how regional differences in the developing brain shape diffuse midline glioma formation.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.